EZH2 and melanoma: He et al., transferred Ezh2fl/flCd4Cre Pmel CD8+ T cells into melanoma B16-tumor-bearing mice and demonstrated the inability of these cells to mediate tumor growth inhibition similar to cells that contained sufficient amounts of EZH2 [185,187].